DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST). To view the live webcast, visit the UBS page here and create a free registration.About DaVita Inc.DaVita (NYSE: DVA) is a health care provider focused on transforming c ...

The company's profitability is going in the wrong direction for many investors.Dialysis specialist DaVita (DVA -10.79%) had quite the Wednesday to forget, as investors sold out of its stock following the company's latest-earnings release. On the back of news that profitability was notably lower than expected, those folks left DaVita shares with a more-than 10% decline in value on the day. This was significantly worse than the 0.3% dip of the S&P 500 index that trading session.Revenue rose while profitabilit ...

DaVita Inc. (DVA) delivered adjusted earnings per share (EPS) of $2.59 in the third quarter of 2024, down 9.1% year over year. The figure also missed the Zacks Consensus Estimate by 6.2%. GAAP EPS for the quarter was $2.50, reflecting a decline of 4.6% year over year. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. DaVita's Revenues in Detail Revenues of $3.26 billion in the third quarter increased 4.6% year over year. The figure surpassed the Zacks Consensus Estimate by 1.3%. Per ma ...

DaVita Inc. (NYSE:DVA) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - Barclays AJ Rice - UBS Pito Chickering - Deutsche Bank Lisa Clive - Bernstein Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Justin Lake - Wolfe Research Operator Good evening. My name is Michelle and I will be your co ...

DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.85 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -6.16%. A quarter ago, it was expected that this kidney dialysis provider would post earnings of $2.47 per share when it actually produced earnings of $2.59, delivering a surprise of 4.86%.Over the last four quart ...

. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |---------------------------------------------------------------------|-------------------------------------------|-------------------------------| | For the | transition per ...

Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 3rd Quarter 2024 Results Denver, Colorado, October 29, 2024 — DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez, CEO of DaVita Inc. "And, in light of recent severe storms, I am grateful for the remarkable resilience of ou ...

DENVER, Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez, CEO of DaVita Inc. "And, in light of recent severe storms, I am grateful for the remarkable resilience of our patients and our frontline caregivers." Financial and operating highlights for the quart ...

DaVita Inc. (DVA) is scheduled to report third-quarter 2024 results on Oct. 29, after the closing bell.In the last reported quarter, the company’s earnings per share (EPS) of $2.59 surpassed the Zacks Consensus Estimate by 4.9%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 24.2%, on average.For third-quarter 2024, the Zacks Consensus Estimate for revenues is pegged at $3.22 billion, implying an improvement of 3.2 ...

DENVER and SAN DIEGO, Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the results of five innovative research projects at the American Society of Nephrology (ASN)'s annual Kidney Week meeting, which is currently underway in San Diego, CA. With a focus on improving racial equity in transplantation and key measures of clinical quality such as hospitalizations, DCR works to tackle pressing issues ...